| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | FB39E94UXK |
| InChI Key | SQZJGTOZFRNWCX-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H22F9N3O2 |
| Molecular Weight | 507.4 |
| AlogP | 5.05 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 36.02 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 34.0 |
| Primary Target | |
|---|---|
| Monoacylglycerol lipase |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2D
Cytochrome P450 2D6
|
- | 6500 | - | - | - | |
|
Enzyme
Hydrolase
|
- | 2-14 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Tourette Syndrome | 2 | D005879 | ClinicalTrials |
| Pain | 1 | D010146 | ClinicalTrials |
| Dyspepsia | 1 | D004415 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3945728 |
| DrugBank | DB16036 |
| FDA SRS | FB39E94UXK |
| Guide to Pharmacology | 10062 |
| PubChem | 71657619 |
| SureChEMBL | SCHEMBL15100632 |